Glycerides as prodrugs. 2. 1,3-Dialkanoyl-2-(2-methyl-4-oxo-1,3-benzodioxan-2-yl)glycerides (cyclic aspirin triglycerides) as antiinflammatory agents.
A series of 1,3-dialkanoyl-2-(2-methyl-4-oxo-1,3-benzodioxan-2-yl)glycerides ("cyclic aspirin triglycerides") was synthesized. They demonstrated essentially all the systemic antiinflammatory activity associated with aspirin in the carrageenin-induced rat paw edema test. Examination of the rat stomachs showed that the 1,3-didecanoyl derivative did not cause gastric lesions.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis*; D001241:Aspirin / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000503:physiopathology; D008297:Male; D051381:Rats; D012459:Salicylates / Q000097:blood; D013276:Stomach Ulcer / Q000139:chemically induced; D014280:Triglycerides / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D012459:Salicylates; D014280:Triglycerides; D002351:Carrageenan; D001241:Aspirin